KYTX Kyverna Therapeutics, Inc.
Healthcare · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $45.4M | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $2.0M | $292.8K |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$47.4M6 buy days
Sold$292.8K1 sell day
Net insider flow+$47.1Mnet buying · 5 years
Latest trade2025-12-18Westlake BioPartners Fund I, L.P.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Buy | Westlake BioPartners Fund I, L.P. | 10% owner | 133,333 | $7.50 | $1,000.0K | 1 |
| 2025-12-18 | Buy | SEIDENBERG BETH C | Director | 133,333 | $7.50 | $1,000.0K | 1 |
| 2025-12-15 | Sell | Walker Karen Marie | Other C-suite | 23,998 | $12.20 | $292.8K | 1 |
| 2024-02-12 | Buy | GILEAD SCIENCES, INC. | 10% owner | 910,000 | $22.00 | $20.0M | 1 |
| 2024-02-12 | Buy | Rubin Michael P. | Other | 450,000 | $22.00 | $9.9M | 1 |
| 2024-02-12 | Buy | Bain Capital Life Sciences Investors, LLC | 10% owner | 450,000 | $22.00 | $9.9M | 1 |
| 2024-02-12 | Buy | Vida Ventures, LLC | 10% owner | 253,136 | $22.00 | $5.6M | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 10% owner | $20.0M | $0 | 2024-02-12 |
| Bain Capital Life Sciences Investors, LLC | 10% owner | $9.9M | $0 | 2024-02-12 |
| Rubin Michael P. | Other | $9.9M | $0 | 2024-02-12 |
| Vida Ventures, LLC | 10% owner | $5.6M | $0 | 2024-02-12 |
| SEIDENBERG BETH C | Director | $1,000.0K | $0 | 2025-12-18 |
| Westlake BioPartners Fund I, L.P. | 10% owner | $1,000.0K | $0 | 2025-12-18 |
| Walker Karen Marie | Other C-suite | $0 | $292.8K | 2025-12-15 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-02-12 | 4 | $45.4M | 46 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.